Reports on the approval on the use of heart failure drug BiDil from NitroMed in African American patients by the U.S. Food and Drug Administration in 2005. Indications of the approval; Information on the chemical composition of the drug; Reasons for the discontinuance of the African American Heart Failure Trial of NitroMed.